Evidence map›Paper›PMID 37781125›Full record

ReviewFrontiers in nutrition2023

Selenium intake and multiple health-related outcomes: an umbrella review of meta-analyses.

Puze Wang, Bo Chen, Yin Huang, Jin Li, Dehong Cao, Zeyu Chen, Jinze Li, Biao Ran, Jiahao Yang, Ruyi Wang and 3 more

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Frontiers in nutrition, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07764328 (A Randomized, Double-blind, Placebo-controlled Study Evaluating the Impact of Milamend on Quality of Life and Hormonal Health in Women With Self-Reported Symptoms Associated With Polycystic Ovary Syndrome), which is not on this map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07764328 narecruitingnot on this mapstarted 2025, after this paper: background citation

A Randomized, Double-blind, Placebo-controlled Study Evaluating the Impact of Milamend on Quality of Life and Hormonal Health in Women With Self-Reported Symptoms Associated With Polycystic Ovary Syndrome (PCOS)

TypeinterventionalSponsorMila Mend Inc.Ran2025 to 2026Enrolled225ConditionsPolycystic Ovarian Syndrome (PCOS)ArmsA dietary supplement powder for women, Placebo
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Endocrine-Metabolic Crosstalk Between Diabetes Mellitus and Hypothyroidism: From Network Mechanisms to Translational Stratification.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Puze WangDepartment of Urology, West China Hospital, Sichuan University, Chengdu, China.
Bo ChenDepartment of Urology, West China Hospital, Sichuan University, Chengdu, China.
Yin HuangDepartment of Urology, West China Hospital, Sichuan University, Chengdu, China.
Jin LiDepartment of Urology, West China Hospital, Sichuan University, Chengdu, China.
Dehong CaoDepartment of Urology, West China Hospital, Sichuan University, Chengdu, China.
Zeyu ChenDepartment of Urology, West China Hospital, Sichuan University, Chengdu, China.
Jinze LiDepartment of Urology, West China Hospital, Sichuan University, Chengdu, China.
Biao RanDepartment of Urology, West China Hospital, Sichuan University, Chengdu, China.
Jiahao YangDepartment of Urology, West China Hospital, Sichuan University, Chengdu, China.
Ruyi WangDepartment of Urology, West China Hospital, Sichuan University, Chengdu, China.
Qiang WeiDepartment of Urology, West China Hospital, Sichuan University, Chengdu, China.
Qiang DongDepartment of Urology, West China Hospital, Sichuan University, Chengdu, China.
Liangren LiuDepartment of Urology, West China Hospital, Sichuan University, Chengdu, China.
Sichuan University · CNWest China Hospital of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Selenium is an essential trace metalloid element that is associated with fundamental importance to human health. Our umbrella review aimed to evaluate the quality of evidence, validity, and biases in the relationship between selenium intake and health-related outcomes according to published systematic reviews with pooled data and meta-analyses. Selenium intake is associated with a decreased risk of digestive system cancers, all-cause mortality, depression, and Keshan disease, when in children reduce the risk of Kashin-Beck disease. Additionally, selenium supplementation can improve sperm quality, polycystic ovary syndrome, autoimmune thyroid disease, cardiovascular disease, and infective outcomes. Selenium supplementation also has relationship with a decreased concentration of serum lipids including total cholesterol and very low-density lipoprotein cholesterol. However, no evidence has shown that selenium is associated with better outcomes among patients in intensive care units. Furthermore, selenium intake may be related with a higher risk of type 2 diabetes and non-melanoma skin cancers. Moreover, most of included studies are evaluated as low quality according to our evidence assessment. Based on our study findings and the limited advantages of selenium intake, it is not recommended to receive extra supplementary selenium for general populations, and selenium supplementation should not be continued in patients whose selenium-deficient status has been corrected.

Indexed as

healthmeta-analysisnutrientseleniumumbrella review

Identifiers

PMID37781125
PMCPMC10534049
OpenAlexW4386700001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.